Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132142) titled 'Hyperbaric oxygen therapy for covert hepatic encephalopathy (CHE) in patients with liver cirrhosis: a prospective, randomized controlled, open-label clinical trial' on Sept. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Army Medical Center of PLA
Condition:
Covert hepatic encephalopathy in cirrhosis
Intervention:
Control group:Receive treatment with lactulose
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-10
Target Sample Size: Control group:145;Experimental group:145;
Countries of Recruitment:
China
To know more, visit https://www....